• 제목/요약/키워드: Respiratory care

검색결과 1,430건 처리시간 0.032초

소아중환자실 환아의 호흡기계 의료장치 관련 욕창 발생 관련 특성 (Characteristics Influencing the Occurrence of Respiratory Medical Device-related Pressure Ulcers in the Pediatric Intensive Care Unit)

  • 김혜경;김영혜;손현미
    • Child Health Nursing Research
    • /
    • 제25권2호
    • /
    • pp.133-142
    • /
    • 2019
  • Purpose: This prospective study was conducted to determine the incidence and related characteristics of respiratory medical device-related pressure ulcers (MDRPU) in children admitted to a pediatric intensive care unit (PICU). Methods: The participants were 184 children who were admitted to the PICU of P University Hospital from April 2016 to January 2017. Data were collected on the occurrence of respiratory MDRPU and characteristics regarding the application of respiratory medical devices. Results: Respiratory MDRPU occurred in 11.9% of participants (58.3%: stage I ulcers, 37.5%: mucosal ulcers). The devices associated with respiratory MDRPU were endotracheal tubes (54.2%), high-flow nasal cannulas (37.5%), and oximetry probes (8.3%). Respiratory MDRPU associated with an endotracheal tube were significant differences according to the site and strength of fixation, the use of a bite block and adhesive tape, skin dryness, and edema. In high-flow nasal cannulas, significant differences were found according to the site of fixation, immobility after fixation, and skin dryness. Conclusion: The occurrence of respiratory MDRPU is significantly affected by the method and strength of fixation, as well as skin dryness and edema. Therefore, appropriate consideration of these factors in nursing care can help prevent respiratory MDRPU.

질 성형을 위한 실리콘 액 주입 후 발생한 급성 호흡 곤란 증후군 1예 (A Case of Acute Respiratory Distress Syndrome Induced by Injection of Silicone Fluid for Colpoplasty)

  • 정창욱;전익수;장재영;박지은;송춘영;김성헌;강경우
    • Tuberculosis and Respiratory Diseases
    • /
    • 제57권2호
    • /
    • pp.193-196
    • /
    • 2004
  • 저자들은 실리콘 액을 이용한 질 성형술 후에 급성호흡 곤란 증후군을 보인 환자에서 경기관지 폐생검으로 실리콘에 의한 것으로 생각되는 폐포 대식세포내의 봉입체를 확인하고 대증적인 치료로 호전된 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

호흡지지요법을 적용 중인 중환자실 입원환자의 액티그래피 측정 수면특성 (Actigraphy-Based Assessment of Sleep Parameters in Intensive Care Unit Patients Receiving Respiratory Support Therapy)

  • 강지연;권용빈
    • 중환자간호학회지
    • /
    • 제15권3호
    • /
    • pp.115-127
    • /
    • 2022
  • Purpose : This study aimed to investigate sleep parameters and to identify differences according to respiratory support therapy, sedation, and pain medication in intensive care unit (ICU) patients. Methods : In this observational study, sleep parameters were measured using actigraphy. We observed 45 sleep events in 30 ICU patients receiving respiratory support therapy. We measured the sleep parameters, time, efficiency, and wakefulness after sleep onset (WASO). The differences in sleep parameters according to the respiratory support therapy were analyzed using the Mann-Whitney U test. Results : The average daily sleep time of the participants was 776.66±276.71 minutes, of which more than 60% accounted for daytime sleep. During night sleep, the duration of WASO was 156.93±107.91 minutes, and the frequency of WASO was 26.02±25.82 times. The high flow nasal cannula (HFNC) group had a significantly shorter night sleep time (𝑥2=7.86, p =.049), a greater number of WASO (𝑥2=5.69, p =.128), and a longer WASO duration (𝑥2=8.75, p =.033) than groups of other respiratory therapies. Conclusion : ICU patients on respiratory support therapy experienced sleep disturbances such as disrupted circadian rhythm and sleep fragmentation. Among respiratory support regimens, HFNC was associated with poor sleep parameters, which appears to be associated with the insufficient use of analgesics. The results of this study warrant the development of interventions that can improve sleep in ICU patients receiving respiratory support, including HFNC.

비장티푸스성 살모넬라 감염으로 발생한 농흉과 종격동염 1예 (A Case of Empyema and Mediastinitis by Non-typhi Salmonella)

  • 양서윤;곽희원;송주한;전은주;최재철;신종욱;김재열;박인원;최병휘
    • Tuberculosis and Respiratory Diseases
    • /
    • 제65권6호
    • /
    • pp.537-540
    • /
    • 2008
  • NTS의 호흡기계 감염은 매우 드문 질환으로 보통 후천성 면역 결핍증, 악성 종양, 교원성 혈관 질환, 스테로이드의 장기간 사용, 겸상적혈구 빈혈증, 당뇨 환자에서 나타난다. 하지만 저자들은 특별한 면역성 질환을 갖고 있지 않은 26세 남자에서 농흉과 종격동염을 진단 후, 환자의 흉수에서 비장티푸스성 살모넬라균이 동정된 1예를 경험하였기에 문헌 고찰과 함께 보고한다.

Modified high-flow nasal cannula for children with respiratory distress

  • Itdhiamornkulchai, Sarocha;Preutthipan, Aroonwan;Vaewpanich, Jarin;Anantasit, Nattachai
    • Clinical and Experimental Pediatrics
    • /
    • 제65권3호
    • /
    • pp.136-141
    • /
    • 2022
  • Background: High-flow nasal cannula (HFNC) is a noninvasive respiratory support that provides the optimum flow of an air-oxygen mixture. Several studies demonstrated its usefulness and good safety profile for treating pediatric respiratory distress patients. However, the cost of the commercial HFNC is high; therefore, the modified high-flow nasal cannula was developed. Purpose: This study aimed to compare the effectiveness, safety, and nurses' satisfaction of the modified system versus the standard commercial HFNC. Methods: This prospective comparative study was performed in a tertiary care hospital. We recruited children aged 1 month to 5 years who developed acute respiratory distress and were admitted to the pediatric intensive care unit. Patients were assigned to 2 groups (modified vs. commercial). The effectiveness and safety assessments included vital signs, respiratory scores, intubation rate, adverse events, and nurses' satisfaction. Results: A total of 74 patients were treated with HFNC. Thirtynine patients were assigned to the modified group, while the remaining 35 patients were in the commercial group. Intubation rate and adverse events did not differ significantly between the 2 groups. However, the commercial group had higher nurses' satisfaction scores than the modified group. Conclusion: Our findings suggest that our low-cost modified HFNC could be a useful respiratory support option for younger children with acute respiratory distress, especially in hospital settings with financial constraints.

Summary of Korean Asthma Guideline

  • Chin Kook Rhee;Ji-Yong Moon;Hyonsoo Joo;Ji Ye Jung;Jung-Kyu Lee;Kyung Hoon Min;Hyeon-Kyoung Koo;Seong Yong Lim;Hyoung Kyu Yoon;Sang Yeub Lee;The Korean Academy of Tuberculosis and Respiratory Diseases (KATRD)
    • Tuberculosis and Respiratory Diseases
    • /
    • 제86권3호
    • /
    • pp.158-165
    • /
    • 2023
  • Asthma is a chronic inflammatory airway disease that is characterized by variable airflow obstruction. The Korean Asthma Study Group of the Korean Academy of Tuberculosis and Respiratory Diseases has recently updated the Korean Asthma Guideline. This review summarizes the updated Korean Asthma Guideline. Asthma prevalence is increasing worldwide, and in Korea. Variable airflow obstruction can be confirmed by bronchodilator response or other tests, and should be established prior to the controller medication. A low-dose inhaled corticosteroid-formoterol is used to alleviate symptoms in all treatment step, and it can be used as a controller as well as reliever in steps 3-5. This approach is preferred, because it reduces the risk of severe exacerbations, compared to the use of short-acting β2-agonist as reliever. In severe asthma, phenotype/endotype based on the underlying inflammation should be evaluated. For type 2 severe asthma, the biologics should be considered.

지역 사회 획득성 폐렴에 동반된 횡문근 융해증 1예 (A Case of Rhabdomyolysis with Community Acquired Pneumonia)

  • 강영애;임재준;김영환;한성구;심영수;유철규
    • Tuberculosis and Respiratory Diseases
    • /
    • 제58권1호
    • /
    • pp.59-63
    • /
    • 2005
  • 67세 남자가 발열과 기침, 호흡곤란을 주소로 내원하였고 지역 사회 획득성 폐렴 의심 하에 항생제 치료를 시작하였다. 입원 경과 중 하지 근위약감과 혈청 CK 상승, 마이오글로빈뇨를 보여 지역 사회 획득성 폐렴에 동반된 횡문근 융해증 의심 하에 항생제 치료와 횡문근 융해증에 대한 보존적 치료를 유지하였다. 이후 폐렴의 호전과 함께 횡문근 융해증도 호전되어 퇴원하였다.

Pectolinarigenin ameliorated airway inflammation and airway remodeling to exhibit antitussive effect

  • Quan He;Weihua Liu;Xiaomei Ma;Hongxiu Li;Weiqi Feng;Xuzhi Lu;Ying Li;Zi Chen
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제28권3호
    • /
    • pp.229-237
    • /
    • 2024
  • Cough is a common symptom of several respiratory diseases. However, frequent coughing from acute to chronic often causes great pain to patients. It may turn into cough variant asthma, which seriously affects people's quality of life. For cough treatment, it is dominated by over-the-counter antitussive drugs, such as asmeton, but most currently available antitussive drugs have serious side effects. Thus, there is a great need for the development of new drugs with potent cough suppressant. BALB/c mice were used to construct mice model with cough to investigate the pharmacological effects of pectolinarigenin (PEC). Hematoxylin-eosin and Masson staining were used to assess lung injury and airway remodeling, and ELISA was used to assess the level of inflammatory factor release. In addition, inflammatory cell counts were measured to assess airway inflammation. Airway hyperresponsiveness assay was used to assess respiratory resistance in mice. Finally, we used Western blotting to explore the potential mechanisms of PEC. We found that PEC could alleviate lung tissue injury and reduce the release of inflammatory factors, inhibit of cough frequency and airway wall collagen deposition in mice model with cough. Meanwhile, PEC inhibited the Ras/ERK/c-Fos pathway to exhibit antitussive effect. Therefore, PEC may be a potential drug for cough suppression.